Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
Clinical trial NCT06739044 · COMPLETED
Trial details
- NCT number
- NCT06739044
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2024-10-11
- Enrollment
- 494
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.